|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
These excerpts taken from the RVBD 10-K filed Feb 23, 2009. Research and Development Continued investment in research and development is critical to our business. To this end, we have assembled a team of engineers with expertise in various fields, including networking, applications, storage and systems management. We have invested significant time and financial resources into the development of our products. We plan to expand our product offerings and solutions capabilities in the future and plan to dedicate significant resources to these continued research and development efforts. Further, as we expand internationally and into different sectors, we may incur additional costs to conform our products to comply with local laws or local product specifications. Research and development expenses were $58.7 million, $39.7 million, and $19.2 million in 2008, 2007, and 2006, respectively. Research and Development Continued investment in research and development is critical to our business. To this end, we have assembled a team of engineers with expertise Research and development expenses were $58.7 million, $39.7 million, and $19.2 million in 2008, 2007, Research and Development All costs to develop our products are expensed as incurred. SIZE="2">2. NET INCOME (LOSS) PER COMMON SHARE Basic net income (loss) per common share is computed by dividing net
72 Table of ContentsRIVERBED TECHNOLOGY, INC. FACE="ARIAL" SIZE="2">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
FACE="ARIAL" SIZE="2">The following table sets forth the computation of income (loss) per share:
The following weighted average outstanding options and RSUs were excluded from the computation of diluted
Stock options outstanding with an exercise price lower than our average stock price for the periods Stock options outstanding with an exercise price higher than our average stock price for the periods These excerpts taken from the RVBD 10-K filed Feb 15, 2008. Research and Development All costs to develop our products are expensed as incurred. Software development costs are capitalized beginning when a products technological feasibility has been established and ending when a product is available for general release to customers. Generally, our products are released soon after technological feasibility has been established. As a result, costs subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred. Research and Development STYLE="margin-top:6px;margin-bottom:0px; text-indent:5%">All costs to develop our products are expensed as incurred. Software development costs are capitalized beginning when a products technological feasibility hasbeen established and ending when a product is available for general release to customers. Generally, our products are released soon after technological feasibility has been established. As a result, costs subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred. This excerpt taken from the RVBD 10-Q filed Apr 27, 2007. Research and Development All costs to develop our products are expensed as incurred. Software development costs can be capitalized beginning when a products technological feasibility has been established and ending when a product is available for general release to customers. Generally, our products are released soon after technological feasibility has been established. As a result, costs subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred.
Basic net income (loss) per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by giving effect to all potential dilutive common shares, including options, common stock subject to repurchase, warrants and convertible preferred stock.
10
Table of ContentsThe following table sets forth the computation of income (loss) per share:
The following weighted average outstanding options, common stock subject to repurchase and convertible preferred stock were excluded from the computation of diluted net loss per common share for the periods presented because including them would have had an antidilutive effect:
This excerpt taken from the RVBD 10-K filed Feb 9, 2007. Research and Development All costs to develop our products are expensed as incurred. Software development costs are capitalized beginning when a products technological feasibility has been established and ending when a product is available for general release to customers. Generally, our products are released soon after technological feasibility has been established. As a result, costs subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred. This excerpt taken from the RVBD 10-Q filed Oct 31, 2006. Research and Development All costs to develop our products are expensed as incurred. Software development costs can be capitalized beginning when a products technological feasibility has been established and ending when a product is available for general release to customers. Generally, our products are released soon after technological feasibility has been established. As a result, costs subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred. | EXCERPTS ON THIS PAGE:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||